NDC codes

416497 NDC codes with hospital pricing data in the network.

• NDC 00378-0473-01 — Divalproex extended-release 500 mg tabletAI (123 hospitals, 26,352–26,874 samples)
• NDC 70010-0770-05 — METHOCARBAMOL 750 MG TABLETAI (164 hospitals, 26,333–26,873 samples)
• NDC 63323-0417-01 — Cisatracurium besylate injection, 20 mg/10 mLAI (171 hospitals, 25,965–26,865 samples)
• NDC 69238-1835-01 — LEVOTHYROXINE 112 MCG TABLETAI (156 hospitals, 26,332–26,863 samples)
• NDC 50268-0603-15 — Nortriptyline 10 mg oral capsuleAI (221 hospitals, 26,332–26,863 samples)
• NDC 63739-0673-10 — LOSARTAN 25 MG TABLETAI (330 hospitals, 26,332–26,863 samples)
• NDC 00904-6824-61 — Hydrocodone-acetaminophen 5 mg/325 mg tabletsAI (264 hospitals, 26,332–26,863 samples)
• NDC 00409-6637-34 — Sodium bicarbonate 8.4% intravenous solutionAI (210 hospitals, 25,889–26,861 samples)
• NDC 68462-0293-01 — Verapamil 180 mg extended-release tabletsAI (772 hospitals, 26,338–26,860 samples)
• NDC 08290-3065-12 — Heparin injection syringe (10 units per mL)AI (34 hospitals, 26,279–26,855 samples)
• NDC 00378-0018-05 — Metoprolol tartrate 25 mg tabletAI (151 hospitals, 26,331–26,853 samples)
• NDC 50268-0167-15 — Chlorthalidone 25 mg tabletsAI (262 hospitals, 26,331–26,853 samples)
• NDC 63739-0973-10 — Potassium chloride 20 mEq extended-release tabletAI (302 hospitals, 26,331–26,853 samples)
• NDC 10370-0832-11 — Diltiazem extended-release 300 mg capsuleAI (150 hospitals, 26,331–26,853 samples)
• NDC 00904-6705-06 — PROPRANOLOL 20 MG TABLETAI (172 hospitals, 26,331–26,853 samples)
• NDC 61314-0144-05 — Brimonidine tartrate 0.15% eye dropsAI (531 hospitals, 25,826–26,843 samples)
• NDC 00904-6558-61 — Morphine sulfate extended-release 30 mg tabletAI (476 hospitals, 26,275–26,842 samples)
• NDC 31722-0005-30 — mesalamine 1,000 mg rectal suppositoryAI (258 hospitals, 25,967–26,840 samples)
• NDC 69374-0523-21 — Fentanyl in saline IV bagAI (94 hospitals, 25,426–26,839 samples)
• NDC 63323-0412-25 — Midazolam 5 mg/mL injectionAI (322 hospitals, 24,754–26,833 samples)
• NDC 63323-0185-07 — Sterile water for injectionAI (278 hospitals, 26,602–26,827 samples)
• NDC 63739-0570-10 — Simvastatin 5 mg tablets, blister packAI (286 hospitals, 26,159–26,825 samples)
• NDC 68084-0282-01 — Carbidopa-levodopa 50-200 mg extended-release tabletsAI (363 hospitals, 26,328–26,823 samples)
• NDC 00143-9983-91 — Cefazolin antibiotic injection, 10 gram vialAI (350 hospitals, 24,159–26,823 samples)
• NDC 00338-0048-04 — sodium chloride 0.9 % irrigation solutionAI (566 hospitals, 25,644–26,823 samples)
• NDC 68180-0122-02 — Cephalexin 500 mg capsulesAI (121 hospitals, 26,327–26,813 samples)
• NDC 60793-0854-01 — levothyroxine 100 mcg tabletAI (114 hospitals, 26,327–26,813 samples)
• NDC 55150-0238-05 — Dexamethasone sodium phosphate injection, 4 mg/mLAI (205 hospitals, 25,106–26,807 samples)
• NDC 00169-4060-12 — LIRAGLUTIDE PENAI (249 hospitals, 25,174–26,803 samples)
• NDC 68462-0799-17 — Nystatin-triamcinolone topical ointmentAI (130 hospitals, 26,004–26,796 samples)
• NDC 17478-0714-10 — Ciprofloxacin eye dropsAI (136 hospitals, 26,004–26,796 samples)
• NDC 00713-0655-40 — Triamcinolone acetonide 0.1% dental pasteAI (365 hospitals, 25,832–26,795 samples)
• NDC 25021-0751-10 — Pantoprazole sodium 40 mg IV injectionAI (420 hospitals, 25,611–26,790 samples)
• NDC 00009-0758-01 — Methylprednisolone sodium succinate 500 mg injectionAI (839 hospitals, 19,202–26,780 samples)
• NDC 63323-0820-74 — Lipid emulsion for IV nutrition, 250 mL bagAI (529 hospitals, 26,376–26,772 samples)
• NDC 60505-0363-01 — Ofloxacin 0.3% eye drops, 5 mL bottleAI (497 hospitals, 25,789–26,761 samples)
• NDC 68516-5214-05 — Human albumin 5% solution, 50 mL vialAI (428 hospitals, 26,671–26,752 samples)
• NDC 50742-0550-05 — Fentanyl 72-hour skin patch, 25 mcg per hourAI (147 hospitals, 25,980–26,745 samples)
• NDC 00065-0396-05 — Cyclogyl 1% eye dropsAI (402 hospitals, 25,747–26,737 samples)
• NDC 16714-0671-02 — Ondansetron 4 mg/5 mL oral liquidAI (256 hospitals, 22,186–26,722 samples)
• NDC 00338-1148-03 — Amino acid, dextrose and electrolyte IV solutionAI (284 hospitals, 26,519–26,717 samples)
• NDC 64253-0202-30 — Sodium chloride 0.9% saline flush syringeAI (183 hospitals, 26,463–26,715 samples)
• NDC 00143-9384-01 — Fosaprepitant 150 mg IV injectionAI (542 hospitals, 25,141–26,707 samples)
• NDC 59310-0304-80 — Beclomethasone inhaler 80 mcgAI (429 hospitals, 25,424–26,702 samples)
• NDC 16714-0268-01 — TRIAMCINOLONE ACETONIDE 0.5 % TOPICAL OINTMENTAI (131 hospitals, 25,751–26,696 samples)
• NDC 50268-0451-15 — Isosorbide mononitrate extended-release 30 mg tabletAI (167 hospitals, 26,222–26,690 samples)
• NDC 51552-0269-09 — Tetracaine hydrochloride powderAI (94 hospitals, 25,309–26,686 samples)
• NDC 68382-0384-01 — Desmopressin nasal sprayAI (132 hospitals, 25,923–26,679 samples)
• NDC 63739-0591-10 — Gabapentin 100 mg capsulesAI (329 hospitals, 26,074–26,677 samples)
• NDC 00078-0792-05 — Neomycin, polymyxin and dexamethasone eye dropsAI (47 hospitals, 25,775–26,675 samples)